Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02432729 · ClinicalTrials.gov registry record
A Smoking Cessation Study to Understand the Biological and Functional Changes After One Year of Smoking Cessation
A clinical trial, sponsored by Philip Morris Products S.A..
- Completed
- Registry status
- 1,184
- Enrollment target
NCT02432729 is a clinical trial that has completed, run by Philip Morris Products S.A.. The registered enrollment target is 1,184 participants.
The verdict
NCT02432729 has completed, sponsored by Philip Morris Products S.A..
- COMPLETED
- Registry status
- 1,184 participants
- Enrollment target
Study Summary
The purpose of this study was to understand the biological and functional changes after one year of smoking cessation and to collect data on a broad range of biomarkers of exposure (BoExp) and biomarkers of effect (BoE).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,184 participants |
| Start Date | 2015-05-05 |
| Est. Completion | 2018-04-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02432729
The ClinicalTrials.gov registry entry for NCT02432729 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,184 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philip Morris Products S.A., which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02432729 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02432729 about?
NCT02432729 is a clinical study titled "A Smoking Cessation Study to Understand the Biological and Functional Changes After One Year of Smoking Cessation". The purpose of this study was to understand the biological and functional changes after one year of smoking cessation and to collect data on a broad range of biomarkers of exposure (BoExp) and biomarkers of effect (BoE).
What is the current status of trial NCT02432729?
This trial is currently completed. The enrollment target is 1,184 participants. The study started on 2015-05-05. Estimated completion is 2018-04-27.
Who is sponsoring clinical trial NCT02432729?
This trial is sponsored by Philip Morris Products S.A., which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.